|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | +39.30% |
|
+39.30% | +131.40% |
| Market Cap | 1.55M 1.35M 1.25M 1.15M 2.19M 148M 2.22M 14.91M 5.86M 72.67M 5.81M 5.68M 250M | P/E 2023 |
-25x | P/E 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 931K 859K 793K 1.51M 102M 1.53M 10.26M 4.03M 50.02M 4M 3.91M 172M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +39.30% | ||
| 1 week | +39.30% | ||
| Current month | +39.30% | ||
| 1 month | +39.30% | ||
| 6 months | +131.40% | ||
| Current year | +131.40% |
| 1 week | 0.28 |  | 0.28 |
| 1 month | 0.28 | | 0.28 |
| Current year | 0.12 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0 | | 0.34 |
| 5 years | 0 | | 0.64 |
| 10 years | 0 | | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 09/01/2018 |
James Anderson
CEO | Chief Executive Officer | 56 | 22/09/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 01/01/2006 |
James Anderson
BRD | Director/Board Member | 56 | 01/12/2006 |
Regina Anderson
CHM | Chairman | 79 | 01/09/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/07/24 | Other | Director | 12,848 | 0.1585% | ||
| 31/07/24 | Other | Director | 7,200 | 0.0888% | ||
| 31/07/24 | Other | Director | 5,600 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +39.30% | +39.30% | +47.37% | +12.90% | 2.29M | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | +3.12% | -2.92% | +26.70% | +51.25% | 357.39B | |
| Weighted average by Cap. | -0.56% | -2.96% | +35.28% | +81.27% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.1M 3.78M 3.49M 6.63M 447M 6.74M 45.18M 17.74M 220M 17.6M 17.21M 757M | 4.98M 4.36M 4.02M 3.71M 7.05M 475M 7.17M 48.05M 18.87M 234M 18.72M 18.31M 805M |
| Net income | -50.24K -43.95K -40.54K -37.44K -71.04K -4.79M -72.24K -484K -190K -2.36M -189K -185K -8.12M | -341K -298K -275K -254K -482K -32.54M -490K -3.29M -1.29M -16.03M -1.28M -1.25M -55.1M |
| Net Debt | -427K -374K -345K -319K -604K -40.77M -615K -4.12M -1.62M -20.08M -1.61M -1.57M -69.05M | -482K -422K -389K -359K -682K -45.98M -693K -4.65M -1.83M -22.65M -1.81M -1.77M -77.87M |
Employees
20
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PCYN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
